IL314682A - Methods for weight loss in a subject with elevated HBA1C - Google Patents

Methods for weight loss in a subject with elevated HBA1C

Info

Publication number
IL314682A
IL314682A IL314682A IL31468224A IL314682A IL 314682 A IL314682 A IL 314682A IL 314682 A IL314682 A IL 314682A IL 31468224 A IL31468224 A IL 31468224A IL 314682 A IL314682 A IL 314682A
Authority
IL
Israel
Prior art keywords
subject
methods
weight loss
elevated hba1c
hba1c
Prior art date
Application number
IL314682A
Other languages
English (en)
Hebrew (he)
Inventor
Shaharyar Khan
Diane Jorkasky
Francisco Portell
Original Assignee
Rivus Pharmaceuticals Inc
Shaharyar Khan
Diane Jorkasky
Francisco Portell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rivus Pharmaceuticals Inc, Shaharyar Khan, Diane Jorkasky, Francisco Portell filed Critical Rivus Pharmaceuticals Inc
Publication of IL314682A publication Critical patent/IL314682A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL314682A 2022-02-07 2023-02-06 Methods for weight loss in a subject with elevated HBA1C IL314682A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307470P 2022-02-07 2022-02-07
US202263382426P 2022-11-04 2022-11-04
PCT/US2023/062065 WO2023150759A1 (en) 2022-02-07 2023-02-06 Methods of weight loss in a subject with elevated hba1c

Publications (1)

Publication Number Publication Date
IL314682A true IL314682A (en) 2024-10-01

Family

ID=85569618

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314682A IL314682A (en) 2022-02-07 2023-02-06 Methods for weight loss in a subject with elevated HBA1C

Country Status (9)

Country Link
US (1) US20250134865A1 (https=)
EP (1) EP4475842A1 (https=)
JP (1) JP2025505632A (https=)
KR (1) KR20240146053A (https=)
AU (1) AU2023214495A1 (https=)
CA (1) CA3243643A1 (https=)
IL (1) IL314682A (https=)
MX (1) MX2024009644A (https=)
WO (1) WO2023150759A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo
WO2022246039A1 (en) * 2021-05-20 2022-11-24 Rivus Pharmaceuticals, Inc. Methods of treating mitochondria-related disorders

Also Published As

Publication number Publication date
MX2024009644A (es) 2024-08-14
EP4475842A1 (en) 2024-12-18
WO2023150759A1 (en) 2023-08-10
AU2023214495A1 (en) 2024-08-15
US20250134865A1 (en) 2025-05-01
JP2025505632A (ja) 2025-02-28
KR20240146053A (ko) 2024-10-07
CA3243643A1 (en) 2023-08-10

Similar Documents

Publication Publication Date Title
GB2582662B (en) Improvements in and relating to non-terrestrial networks
GB201904456D0 (en) Improvements in and relating to a telecommunications network
GB2593745B (en) Improvements in and relating to HARQ in a non-terrestrial network
IL314682A (en) Methods for weight loss in a subject with elevated HBA1C
GB202204156D0 (en) Improvements in and relating to minimisatioin of drive tests in a telecommunication network
HK40119963A (en) Methods of weight loss in a subject with elevated hba1c
GB201912776D0 (en) Improvements in and relating to a guided weapon
GB202311551D0 (en) Shooting stand with balancing weight
GB2620491B (en) Improvements in fuels
EP3892721A4 (en) METHOD FOR CULTIVATING NATURAL KILLER CELLS DERIVED FROM UMBILICAL CORD BLOOD USING TRANSFORMED T LYMPHOCYTES
GB2615610B (en) Cell balancing
CN202707728U (zh) 一种学校课桌的燕尾榫拼接结构
EP4570018A4 (en) Techniques for communicating with uplink-only cell
GB202016469D0 (en) Cohort stratification into endotypes
IL287970A (en) Methods and compositions using tunable auxotropic cells
GB202305490D0 (en) Load balancing in microservice-based core networks
PL3738866T3 (pl) Rama kłonicowa do drewna oraz sposób związany z ramą kłonicową do drewna
GB2618981B (en) Cell balancing circuitry
GB202311355D0 (en) Trigger-based communication in multi-ap context
GB202409145D0 (en) cell balancing
GB202201997D0 (en) Cells and methods
CA216234S (en) Pelvic educational model with stand
GB2585943B (en) Improvements in and relating to HARQ in a non-terrestrial network
GB202408672D0 (en) Cell measurements in network
CA220979S (en) Utility lift